Skip to content
Home
Close Home
Open Home
Journal information
Editorial board
Operations manual
Editorial policies
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Close Read
Open Read
Archive
TOC Alert
Current issue
Information
Close Information
Open Information
Editorial & Peer Review
Ethical policies
Funding
Complaints and appeals
Open access and licensing
Authors
Sponsorship
Contact
Publish
Close Publish
Open Publish
Instructions to authors
Online submission
Español
English
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
ES
EN
TOC Alert
Volume 45 – Number 3
2026
>
Volume 45 - Number 3
Follicular lymphoma: recommendations for next-generation sequencing
2026
>
Volume 45 - Number 3
T-cell lymphomas: recommendations for next-generation sequencing
2026
>
Volume 45 - Number 3
Avatrombopag: más allá de la ficha técnica. Experiencia de un centro
2026
>
Volume 45 - Number 3
Therapeutic plasma exchange: rescue for severe hemolytic anemia associated with Pylera
®
2026
>
Volume 45 - Number 3
Therapeutic strategies in chronic lymphocytic leukemia: efficacy and safety of zanubrutinib in patients with arrhythmias and hemorrhagic risk. Report of two cases
2026
>
Volume 45 - Number 3
Hematologic dysregulation as a sign of inborn errors of immunity: activated PI3Kδ syndrome (APDS) as a model